This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Ophthalmol. 2002;120:204-207.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Intraocular lymphoma is generally of the B-cell type, commonly affecting the posterior segment of the eye, and in most cases is associated with central nervous system (CNS) lymphoma.¹ Primary involvement of the anterior uvea is very rare.^2-4 T-cell lymphoma is not commonly seen in the eye. We describe a patient with non-Hodgkin lymphoma (NHL) of the T-cell type affecting primarily the iris and ciliary body of both eyes as the first manifestation of the systemic disease.

Report of a Case

A 31-year-old man came to our clinic with left anterior uveitis of 4 weeks' duration that was unresponsive to topical steroids. During the previous weeks, he had noticed a progressive worsening of his vision with mild ocular discomfort in his left eye. No pain or redness was present. His history was remarkable for oral drug abuse (3,4-methylene dioxymethamphetamine [Ecstasy]) and lysergic acid diethylamide. He denied intravenous drug administration. On examination, his visual acuity was . . . [Full Text of this Article]

Comment
Corresponding author and reprints: Jacob Pe'er, MD, Department of Ophthalmology, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel (e-mail: peer@md2.huji.ac.il).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience
Frenkel et al.
Br. J. Ophthalmol. 2008;92:383-388.
ABSTRACT | FULL TEXT